FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to gastroenterology, and concerns therapy of inflammatory bowel diseases that is ensured by intravenous introduction of allogenerated mesenchymal stem human bone marrow cells in a dose 1.5-2.0·1011 cells dissolved in physiologic saline 200 ml within 3-4 hours. Administered therapy is considered to be effective, if ferritin "ФНОα" is decreased twice and more and IL-4 is increased in 1.5 times and more, while C-reactive protein is decreased 40 to 21 mkmmol/l.
EFFECT: method allows for therapy of inflammatory bowel diseases under the control of objective indicators of therapeutic effectiveness without application of pharmacological preparations and manifestation of their adverse reaction.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ASSESSING CLINICAL EFFECTIVENESS IN INFLAMMATORY INTESTINAL DISEASES | 2011 |
|
RU2477478C1 |
METHOD OF TREATING INFLAMMATORY INTESTINAL DISEASES | 2011 |
|
RU2463055C2 |
METHOD OF TREATING ULCERATIVE PROCTOSIGMOIDITIS | 2008 |
|
RU2367450C1 |
METHOD FOR EVALUATING CLINICAL EFFECTIVENESS OF MESENCHYMAL STROMAL CELLS FOR INFLAMMATORY INTESTINAL DISEASES | 2011 |
|
RU2463596C1 |
METHOD OF EVALUATING EFFICIENCY OF CROHN'S DISEASE AND ULCERATIVE COLITIS TREATMENT | 2008 |
|
RU2391914C2 |
METHOD OF ULCERATIVE COLITIS AND CROHN'S DISEASE THERAPY | 2011 |
|
RU2460554C1 |
DIAGNOSTIC TECHNIQUE FOR BRONCHIAL OBSTRUCTION ACCOMPANYING INFLAMMATORY INTESTINAL DISEASES | 2011 |
|
RU2451488C1 |
METHOD FOR TREATING SYNDROME OF IRRITATED INTESTINE | 2004 |
|
RU2277424C2 |
METHOD FOR TREATMENT OF IRRITABLE BOWEL SYNDROME | 2006 |
|
RU2314017C1 |
METHOD OF PREDICTING DEVELOPMENT OF IRRITABLE BOWEL SYNDROME | 2007 |
|
RU2337627C1 |
Authors
Dates
2009-08-20—Published
2008-04-10—Filed